NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
July 8, 2026 — NanoViricides receives Outperform rating from Noble Capital Markets with $6 target. Analyst coverage highlights broad-spectrum antiviral NV-387 and pipeline. CEO discusses FDA progress and pandemic threats.
July 8, 2026 — Lantern Pharma launches ZetaOmics, an AI-powered computational biology module of its withZeta.ai platform, automating multi-omic analysis to accelerate cancer research and drug development.
July 8, 2026 — Scottsdale AZ Detox Center now accepts major insurance plans including Cigna, Aetna, and UMR, offering private rooms and executive suites for medically supervised detox from alcohol, opioids, and more.
July 8, 2026 — Learn how to get affordable dental implants without sacrificing quality. Compare providers, explore financing, and save on long-term oral health with this guide from Affordable Dentist Near Me of Longview.
July 8, 2026 — American Heart Association partners with FIFA to train thousands in Hands-Only CPR at 2026 World Cup fan events, aiming to double cardiac arrest survival rates by 2030.
July 8, 2026 — Damaris Nightingale launches 'My Many Selves' podcast exploring consciousness, psychology, neuroscience, AI, and spirituality. A framework for understanding the many selves within.
July 8, 2026 — The Hope House now accepts Cigna, Aetna, and UMR insurance for luxury residential addiction and mental health treatment in Scottsdale, AZ. Verify coverage for evidence-based dual-diagnosis care.
July 8, 2026 — A new study in the Journal of the American Heart Association links alcohol and smoking to both breast cancer and atrial fibrillation in women over 55, highlighting shared risk factors and potential prevention strategies.
July 8, 2026 — Teen anxiety and depression rates are rising, with 1 in 5 adolescents affected. Learn about causes, warning signs, and how providers like Compassion Teens offer evidence-based treatment.
July 8, 2026 — Ignite Counseling Colorado wins 2026 Colorado Companies to Watch award for growth and commitment to compassionate mental health care. New Youth & Family Therapy Center expands services for children and teens.
July 8, 2026 — Dental Studio of Palm Harbor offers comprehensive dental services including teeth whitening, Invisalign, and implants. Led by Dr. Natalie Garcia, the practice prioritizes patient comfort and personalized care in Palm Harbor, FL.
July 8, 2026 — Children's Dentistry of Chattanooga offers fun, fear-free pediatric dental care with sedation, frenectomy, and special needs services. Led by Dr. Clay Goins, it's the 'Disney World of pediatric dentistry' serving Chattanooga area.
July 8, 2026 — Invisalign in Surrey is now available for children at PacificWest Dental Group. Learn how clear aligners offer a discreet, removable alternative to braces for growing smiles.
July 8, 2026 — Future Aesthetica launches clinical-grade cosmetic tattoo training academy in Annandale, Sydney, led by Talina Johnson. Offers lifetime mentorship and health science-based curriculum.
July 7, 2026 — Novartis acquires Myricx Bio for $1.5B, boosting antibody therapeutics. VERAXA Biotech (VRXA) benefits from surging ADC/TCE deal activity. Learn how VERAXA's BiTAC platform positions it for growth.
July 7, 2026 — SS Innovations International wins Outstanding Company at 2026 Surgical Robotics Industry Awards. Learn about the SSi Mantra system's global adoption and regulatory approvals.
July 7, 2026 — United Health Products partners with NAMSA to conduct a clinical study of CelluSTAT Hemostatic Gauze, aiming for FDA approval and market entry in surgical bleeding control.
July 7, 2026 — Oncotelic Therapeutics announces positive safety review for Sapu003 Phase 1b trial, no dose-limiting toxicities, and expansion into Europe. Learn about the Deciparticle nanomedicine platform and its potential in oncology.
July 7, 2026 — Dr. Bob Martin Show rebrands as Health Talk America after 30 years. Hosted by Dr. Adam Brockman, the top health talk radio show reaches millions weekly on 500+ stations. Represented by Agent Alan Morell of CMP.
July 7, 2026 — Oragenics activates all Australian sites for ONP-002 Phase IIa concussion trial, no serious adverse events, targets Q4 2026 data readout and FDA meeting for U.S. development.